Ionis Pharmaceuticals (IONS) Other Non Operating Income (2012 - 2026)

Ionis Pharmaceuticals' Other Non Operating Income history runs 12 years deep, the most recent figure standing at -$456000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 198.06% year-over-year to -$456000.0; the TTM figure through Mar 2026 stood at -$16.3 million (down 1171.63% YoY), while the FY2025 annual figure was -$15.4 million, down 1253.87% from the prior year.
• Other Non Operating Income was -$456000.0 for Q1 2026 at Ionis Pharmaceuticals, up from -$16.3 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $11.2 million in Q2 2023 to a low of -$16.3 million in Q4 2025.
• Historically, Other Non Operating Income has averaged -$419529.4 across 5 years, with a median of $277000.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income soared 6133.33% in 2022, then slumped 5493.05% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $649000.0 in 2022, then slumped by 63.33% to $238000.0 in 2023, then rose by 26.89% to $302000.0 in 2024, then plunged by 5493.05% to -$16.3 million in 2025, then soared by 97.2% to -$456000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$456000.0 (Q1 2026), -$16.3 million (Q4 2025), and $363000.0 (Q3 2025), per Business Quant data.